Last edition
News about Global Pharma
Asia-Pacific Pharmaceutical Logistics Market Set to Surge at 6.68 Percent CAGR
According to a comprehensive analysis, the market size is anticipated to swell from USD 143.22 billion in 2023 to an impressive USD 197.94 billion by 2028.
Global Pharma | 17/01/2024 | By Manvi | 600
First US VasQ Implantation Signals Breakthrough in Vascular Access Surgery
VasQ™, a nitinol-based external support device, plays a crucial role in the surgical creation of an arteriovenous fistula to facilitate maturation into functional access for hemodialysis.
Global Pharma | 17/01/2024 | By Manvi | 759
The FDA has also approved the NaviCam Tether as an accessory for the NaviCam SB Capsule.
Global Pharma | 17/01/2024 | By Manvi | 939
Pharmaceutical Contract Manufacturing Market Size to Hit USD 140 Billion by 2030 Say, Roots Analysis
It is estimated to grow at a compounded annual growth rate of 6.5% during the forecast period (2022-2030).
Global Pharma | 16/01/2024 | By Manvi | 495
Clearview Cancer Institute Partners with OneOncology to Expand Cancer Care Access in Alabama
This strategic partnership, marking Clearview Cancer Institute as the 20th practice to integrate with OneOncology, is geared towards elevating cancer care services across Alabama.
Global Pharma | 16/01/2024 | By Manvi | 674
India Advocates Swift USFDA Inspections at the 14th Trade Policy Forum
The Indian delegation is expected to strongly advocate for expediting USFDA inspections of domestic pharmaceutical firms.
Global Pharma | 16/01/2024 | By Manvi | 367
Swiss Firm SHL Medical Acquires US-based Superior Tooling Inc. to Boost Manufacturing Capabilities
With two new manufacturing sites underway in North Charleston, SC, USA, and Zug, Switzerland, complementing the existing facilities in Taiwan, SHL strategically addresses the growing demand in the autoinjector market.
Global Pharma | 12/01/2024 | By Manvi | 837
AIRS Medical Attains CE Certification for SwiftMR Under EU Medical Device Regulation
This certification allows AIRS Medical to sell its flagship product, 'SwiftMR™,' across the EU (27 countries), Turkey, EEA (Liechtenstein, Iceland, Norway), Great Britain, and Switzerland.
Global Pharma | 12/01/2024 | By Manvi | 737
BioPulse Solutions Marks its Inaugural Year with INR 360 Million Valuation
BioPulse Solutions Pvt Ltd., announces significant milestones and achievements at the start of 2024 as it continues to bring in innovations in bioprocessing technologies that would significantly benefit the biopharma industry.
Global Pharma | 12/01/2024 | By Manvi | 1101
Contract Packaging Predicted to See High Growth in 2024 Ahead of Pharmapack Europe
The new survey results are announced ahead of this month’s Pharmapack Europe 2024 (January 24/25th) – held at the Paris Expo, Porte de Versailles (Hall 7.2) – where more than 5000 attendees and 370 exhibitors are expected.
Global Pharma | 12/01/2024 | By Manvi | 429
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy